[Oral antidiabetics in pregnancy].
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D001645:Biguanides / Q000009:adverse effects; D002271:Carbutamide / Q000009:adverse effects; D002747:Chlorpropamide / Q000009:adverse effects; D005260:Female; D005333:Fetus / Q000187:drug effects; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D007231:Infant, Newborn; D007328:Insulin / Q000627:therapeutic use; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000188:drug therapy*; D013997:Time Factors; D014044:Tolbutamide / Q000009:adverse effects
D001645:Biguanides; D007004:Hypoglycemic Agents; D007328:Insulin; D014044:Tolbutamide; D002271:Carbutamide; D002747:Chlorpropamide
Zur Problematik der oralen Diabetestherapie in der Schwangerschaft.